Tri-Acta Regular Joint and Mobility Dog and Cat Supplement

Key product benefits

Promote healthy cartilage
Maintain collagen and connective tissue
Protect joint tissues
Decrease stiffness
Improve mobility

Integricare developed TRI-ACTA to be a proactive solution for maintaining your pet’s joint health. Our joint supplement does this by combining two key ingredients, glucosamine and chondroitin, which activate alongside MSM (methylsulfonylmethane), a naturally-occurring anti-inflammatory, to promote the generation of new cartilage, muscle, and ligaments in the joint. This synthesis of new cartilage treats the cartilage matrix at the cellular level and allows the body to heal itself.

TRI-ACTA is used in the treatment of age-related soreness, degenerative joint disease, arthritis, and ailments associated with hip dysplasia, injury, or surgery. It is also recommended as a preventative approach to maintain optimal joint health.

TRI-ACTA has been designed to:

Promote healthy cartilage
Maintain collagen and connective tissue
Protect joint tissues
Decrease stiffness
Improve mobility

TRI-ACTA is optimal for:

Preventing joint issues in developing and growing dogs
A complete and balanced diet
Dogs with mild to moderate mobility conditions
Early signs of immobility

Dosage and Ingredients

EVERY 1 G (1000 MG) SERVING CONTAINS:

Glucosamine (Glucosamine Sulfate 250 mg, Glucosamine HCL 250 mg)	500 mg
Methylsulfonylmethane (MSM)	375 mg
Chondroitin Sulfate	125 mg
100% ALL ACTIVE INGREDIENT – NO FILLER!

RECOMMENDED DAILY MAINTENANCE LEVEL:

Under 10 lbs. (4.5kg)	0.5 g
10-35 lbs. (4.5-16 kg)	1 g
35-75 lbs. (16-35 kg)	1.5 g – 2 g
75-100 lbs. (35-50 kg)	2 g – 3 g

DIRECTIONS:

Using the measuring scoop provided, simply sprinkle the desired amount on food.

For optimal results double the recommended daily maintenance level for up to 4 weeks. When the desired improvement is noticeable, decrease dosage to the recommended maintenance level. The servings per dose may be divided over two meals daily.

The time to achieve a positive response will vary depending on the severity of each condition. If improvement is noticed within four weeks, proceed to the maintenance level. If not, continue the loading dose until the desired response is achieved and then reduce to the maintenance dose.